OG2UOPERATOR HEALTH BRIEF
Menu

EVIDENCE • EXPERIENCE • ACCOUNTABILITY

The body kept
the mission.

Operator Syndrome is moving from a clinical framework to empirical evidence and federal policy. The next mission is integrated recovery for the whole operator.

Enter briefing modeRead Scott’s account

CLINICIAN & SOCIAL-WORK BRIEF • UPDATED JULY 17, 2026

“These conditions are interconnected and should not be treated in isolation.”
00 / BRIEFING MODEOPENING • ABOUT 60 SECONDS

What I am asking this room to see.

“Good morning. I’m Scott Roessler. For twenty years I served in Army Special Operations, and I learned to use performance as proof that I was healthy. In 2015, the VA documented twenty-nine diagnoses. I read them as separate problems. My body had not separated any of it. I’m not here to ask you to accept one treatment or one story as proof. I’m here to show you a pattern—and to ask what changes when clinicians, social workers, families and veterans are finally looking at the same whole person.”

KEEP THESE FOUR LANES SEPARATE

01Official policyWhat the Department of War directed
02Peer-reviewed evidenceWhat defined cohorts and measures showed
03Developing researchQuestions under study—not established efficacy
04Lived experienceScott’s account—not a generalizable outcome
THE PATTERN

One complaint may be the visible edge.

Sleep, pain, cognition, mood, endocrine function, relationships and identity can be different expressions of accumulated injury.

THE DISCIPLINE

Name the evidence level every time.

A policy directive, a cross-sectional cohort, an observational intervention and one veteran’s experience answer different questions.

THE ASK

Build a coordinated handoff.

Do not make the veteran carry the full story from specialty to specialty. Share the picture, the plan, the measures and the follow-up.

01 / POLICYTHE JULY 15 BREAKTHROUGH

The Pentagon named Operator Syndrome.

Secretary of War Pete Hegseth directed mandatory annual testosterone-deficiency screening for Active Duty and Reserve Component personnel age 30 and older. Personnel under 30 may request screening during their Periodic Health Assessment.

The memorandum says the protocol supports human-performance optimization while “comprehensively addressing Operator Syndrome.” It orders policy updates by August 15, provider education, clinical decision support and an external advisory council.

Read the official memorandum Read the official statement
02 / EVIDENCE222 ACTIVE-DUTY, TREATMENT-SEEKING SOF PERSONNEL

A constellation of interconnected injury

The 2026 cross-sectional study provides emerging evidence of a cumulative, general burden of persistent posttraumatic behavioral, biological and physiological sequelae in this clinical population.

92.8%Sleep symptoms
83.3%Pain
82.4%Cardiometabolic findings
81.1%Mental-health symptoms
80.2%Headaches
77.5%Cognitive symptoms
73.4%Sensory symptoms
39.2%Endocrine symptoms
Read this correctly.The cohort was treatment-seeking and the design was cross-sectional. These figures describe this clinical cohort; they are not prevalence estimates for the entire SOF community, do not establish causation and do not prove that one intervention treats the full constellation.

Brain + blast

TBI history, cumulative blast exposure, headache, vestibular and sensory changes

Sleep + endocrine

Sleep disruption, apnea, fatigue, testosterone and wider neuroendocrine function

Pain + body

Musculoskeletal injury, chronic pain, inflammation and cardiometabolic health

Mind + cognition

PTSD symptoms, mood, attention, memory, executive function and hypervigilance

Behavior + identity

Alcohol or substance use, anger, control, performance identity and transition

Family + purpose

Marriage, parenting, intimacy, belonging, faith, work and a reason to move forward

Read the PubMed record and abstract
03 / HRTSCREEN EARLIER • DIAGNOSE CAREFULLY • TREAT INDIVIDUALLY

A hormone test is a doorway—not the whole answer.

Endocrine dysfunction is one part of Operator Syndrome. The new policy creates a force-wide screening opportunity. It does not make testosterone replacement automatic, and it does not reduce the whole-operator problem to a single lab value.

WHAT CHANGED

Screening becomes routine

Annual screening enters the PHA for personnel age 30 and older; younger service members may request it.

WHAT COMES NEXT

Clinical systems must follow

The memorandum directs updated policy, education, testing access, decision support and outside expert guidance.

WHAT IT DOES NOT MEAN

A low result is not a treatment plan

VA guidance pairs biochemical assessment with signs, symptoms, potential causes, contraindications and ongoing monitoring.

Clinical context matters.

Traumatic brain injury, pituitary dysfunction, sleep apnea, depression, obesity, chronic opioid exposure and other conditions can overlap with symptoms attributed to low testosterone. VA guidance calls for an individualized evaluation and confirmation of consistently low levels; the policy breakthrough is earlier detection inside a more complete evaluation.

Read the January 2026 VA clinical guidance
04 / RESEARCHTHE EVIDENCE LINE

From a name to measurable change

  1. 2020

    The clinical framework

    Dr. B. Christopher Frueh and colleagues described Operator Syndrome as a recurring constellation of interconnected medical, psychological, behavioral and quality-of-life impairments—not a single diagnosis.

  2. 2024

    Clinical outcomes

    A prospective, open-label observational study of 30 male Special Operations veterans reported large one-month improvements in disability, PTSD, depression and anxiety after a medically monitored magnesium–ibogaine protocol.

  3. 2025

    Brain activity

    EEG analysis in the same observational cohort reported altered cortical oscillations and reduced neural complexity after treatment. These mechanistic findings do not establish clinical efficacy.

  4. 2026

    Structure and brain age

    Structural MRI in the same small observational cohort was associated with increased cortical thickness, subcortical expansion and reduced predicted brain age at one month; the authors caution that T1 MRI is sensitive to nonstructural change.

  5. 2026

    The pattern becomes data

    Dr. Shane W. Adams, Dr. Frueh and colleagues examined 222 treatment-seeking active-duty SOF personnel. The multisystem burden was measurable across sleep, pain, cardiometabolic, mental-health, cognitive, sensory, headache and endocrine domains.

  6. 2026

    Policy recognizes the pattern

    The July 15 Secretary of War memorandum explicitly names Operator Syndrome, mandates testosterone-deficiency screening at age 30 and older, and directs clinical guidance, education and an external advisory council.

30.2 → 5.1

Average WHODAS disability score, baseline to one month

d = 2.54

One-month PTSD effect size in the initial open-label cohort

Controlled trials

The authors’ stated next step to confirm safety and efficacy

Study boundary: The MISTIC work was prospective and observational, not a randomized controlled trial. Participants independently sought treatment, complementary services may have contributed to outcomes, and one-month data were incomplete and varied by measure; four participants did not complete the WHODAS at one month. Group findings must not be assigned to any one participant.

05 / TRIFECTASCOTT ROESSLER • TEAM 1, COHORT 1 • 18-MONTH PARTICIPATION

The SOC-F Trifecta of Treatment Research Study

Scott entered the SOC-F Trifecta of Treatment Research Study in July 2022, beginning hormone replacement therapy through Warrior Health Foundation. His participation, from entry through follow-up, lasted 18 months.

  1. JULY 2022

    Entry + HRT

    Scott began the study and hormone replacement therapy through Warrior Health Foundation.

  2. OCT. 3–NOV. 11, 2022

    Six weeks of MeRT

    He completed six weeks of MeRT at Cardiff Brain Performance Center.

  3. NOV. 14–18, 2022

    Ambio treatment sequence

    At Ambio Life Sciences, Scott received a medically monitored ibogaine flood dose with magnesium—an experience he describes as 37 hours of deep healing—followed by two high-dose, often called “hero-dose,” 5-MeO-DMT experiences.

  4. RETURN TO FLORIDA

    Integration + follow-up

    Scott returned home and continued structured integration with coaches and therapists through the remainder of his 18-month participation.

The study was funded by SOC-F and supported through VETS and Ambio, with research led by Dr. Brandon Weiss and co-PI Dr. Kate Pate. The Trifecta contributes to the research conversation by asking how a sequenced, multimodal model may support the whole operator. Scott’s experience does not establish clinical efficacy on its own.

01 HRT02 MeRT03 Ibogaine + Mg04 5-MeO-DMT ×205 Integration
Research separation

The published Stanford MISTIC papers evaluate a magnesium–ibogaine protocol in a 30-man cohort. They do not evaluate the entire Trifecta sequence. The Trifecta is presented here as developing research and lived experience—not an established standard of care.

OG2U visual brief explaining the July 15 Pentagon testosterone policy and interconnected Operator Syndrome health domains
OG2U research and policy briefing artwork
06 / WHOLE OPERATORWHAT INTEGRATED RECOVERY REQUIRES

Do not send an interconnected injury through disconnected care.

1

Detect the pattern

Ask about lifetime blast and TBI exposure, sleep, pain, hormones, cognition, mood, substance use, relationships and transition—not only the presenting complaint.

2

Coordinate the disciplines

Connect primary care, neurology, sleep, endocrinology, rehabilitation, pain care, behavioral health, social work and family support around one shared picture.

3

Measure real function

Track sleep, pain, cognition, daily function, alcohol and substance use, family stability, work, purpose and the ability to stand down.

4

Integrate the change

Treatment opens a door. Coaching, therapy, peers, family, faith, accountability and daily practice help determine what happens after the intervention.

“Research alone does not heal anyone. What we do with it does.”
THE CLINICIAN + SOCIAL-WORK HANDOFF

Four actions this room can take.

This is a discussion framework, not a validated screening instrument or treatment protocol.

01

At intake

Ask for the service-and-exposure story alongside the symptom list. A veteran who is still performing may still be carrying substantial impairment.

02

At case conference

Put sleep, pain, cognition, endocrine function, mental health, substance use, family and purpose on one shared map.

03

At referral

Name the receiving clinician, the question being asked, the known barriers and who will close the loop with the veteran.

04

At follow-up

Measure function and connection, not only symptoms: sleep, daily life, relationships, work, substance use, safety and a reason to keep moving.

CLOSE WITH THIS

“My ask is simple: when the story crosses specialties, do not make the veteran carry it alone. See the pattern, name what the evidence can and cannot say, and build one coordinated path home.”

24/7 CRISIS SUPPORT

Veterans Crisis Line

Dial 988, then Press 1 • Text 838255

Open official resource
CENTRAL FLORIDA

Orlando Vet Center

Confidential counseling, family support and community referrals in a non-medical setting.

Open official resource
VA HEALTH SYSTEM

VA Orlando Health Care

Medical, mental-health and veteran-care services across the Orlando system.

Open official resource
07 / THE RECORDADAPTED FROM THE OPERATOR’S GUIDE TO THE UNIVERSE™

The Body Kept the Mission

What My Medical Record Revealed Before I Understood the Pattern

In 2015, the VA documented twenty-nine diagnoses. I was thirty-nine years old, still serving in 7th Special Forces Group, and convinced I was fine because I could still work. I could lead a team, plan a mission, brief a commander, and enter a room already looking for what could go wrong. I had spent most of my adult life being rewarded for those abilities, so I used performance as proof of health.

“We counted men, ammunition, distance, time, casualties, and objectives. My body kept a different ledger.”

Mission First. Men First. Pain Later.

I had spent ten years in the Ranger Regiment and another ten as a Green Beret. Eleven combat deployments were behind me, five in Iraq and six in Afghanistan. There had also been years of parachute operations, breaching, gunfights, vehicle crashes, heavy weapons, training injuries, and blast exposure that never made it into a medical record.

PREP found what performance had hidden: traumatic brain injury, chronic PTSD, sleep apnea, migraines, hearing loss, tinnitus, chronic pain, low testosterone, cognitive concerns, insomnia, depression, and damage throughout my spine. I read those diagnoses as separate lines. My body had never separated any of it.

Chris Frueh Put a Name to It

Years later, Dr. B. Christopher Frueh’s work gave me a framework. Operator Syndrome made me ask whether I had been looking at the same accumulated injury from twenty-nine different directions. Then Adams, Frueh, and their colleagues showed that the pattern could be measured across 222 operators whose accumulated problems looked a hell of a lot like mine.

What Followed Me Home

After the November 2022 sequence, I began sleeping. The dreams about killing stopped. Hypervigilance quieted. I had more patience, and fear controlled less of my life. I quit Copenhagen. On August 1, 2023, I stopped drinking. My faith deepened. None of it erased the work. It gave me enough quiet to see the work and enough space to begin doing it.

“The whole man had been carrying the mission, and coming home would require the whole man too.”

Scott Michael Roessler
MSG (Ret.), U.S. Army Special Operations • Founder, OG2U™

GRATITUDE AND RESPECT

Let the evidence lead.

Dr. B. Christopher FruehOperator Syndrome clinical framework
Dr. Shane W. AdamsEmpirical SOF research
Dr. Nolan R. WilliamsStanford MISTIC research team
Dr. Brandon WeissJohns Hopkins • Trifecta research
Dr. Kate PateSOC-F Trifecta research team
08 / SOURCESPRIMARY AND AUTHORITATIVE SOURCES

Read the evidence yourself.

Every major claim on this page is separated by evidence type: policy, empirical research, observational treatment data, developing research or personal testimony.

Policy
Secretary of War memorandum (July 15, 2026)Health and Human Performance Optimization to Enhance Military Readiness
Policy statement
Department of War (July 15, 2026)Enhanced screening protocol to optimize performance and readiness
Framework
Frueh et al. (2020)‘Operator syndrome’: A unique constellation of medical and behavioral health care needs
Empirical study
Adams, Frueh et al. (2026)Persistent behavioral, biological, and physiological sequelae in active-duty treatment-seeking U.S. special operations forces personnel
Clinical outcomes
Cherian et al. (2024)Magnesium–ibogaine therapy in veterans with traumatic brain injuries
Neurophysiology
Lissemore et al. (2025)Effects on cortical oscillations and neural complexity
Neuroimaging
Geoly et al. (2026)Increased cortical thickness and decreased brain age
Safety synthesis
MAPS (2026)Ibogaine Investigator’s Brochure, Version 1
HRT guidance
Veterans Health Administration (2026)Evaluation and Management of Males with Low Testosterone

Medical, legal and research notice. Educational content only; not medical advice, clinical instruction, a validated screening tool or a referral for treatment. Operator Syndrome is a proposed clinical framework, not a formal diagnosis. Ibogaine is a U.S. Schedule I controlled substance, is not FDA-approved, and carries serious cardiac and drug-interaction risks. The psychedelic and neuromodulation interventions described here are not established treatments for Operator Syndrome and should not be pursued outside lawful, appropriately screened and medically supervised settings. The cited MISTIC findings come from a small, prospective, open-label observational study and require confirmation in controlled trials. The Trifecta is developing research. Personal testimony is not proof of efficacy.

CONTINUE THE CONVERSATION

Bring the whole operator into the room.

For clinician education, social-work conversations, veteran advocacy and speaking inquiries.

Visit TheOG2U.comInstagram @og2uofficialCall 850-401-9869